U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H11N4O3S.Na.H2O
Molecular Weight 320.3
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFAMONOMETHOXINE SODIUM MONOHYDRATE

SMILES

O.[Na+].COC1=NC=NC([N-]S(=O)(=O)C2=CC=C(N)C=C2)=C1

InChI

InChIKey=FCRXFGJGZLBJRP-UHFFFAOYSA-N
InChI=1S/C11H11N4O3S.Na.H2O/c1-18-11-6-10(13-7-14-11)15-19(16,17)9-4-2-8(12)3-5-9;;/h2-7H,12H2,1H3;;1H2/q-1;+1;

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.goldbio.com/product/3383/sulfamonomethoxine http://ft.chqmarket.com/en/1059-compound-sulfamonomethoxine-sodium-injection-baclean.html

Sulfamonomethoxine is a long-acting sulfonamide antibiotic. It is active against Streptococcus spp. (Including Streptococcus pneumoniae, Enterococcus spp.), Staphylococcus spp., Escherichia coli, Shigella spp., some strains of Proteus spp., Neisseria gonorrhoeae, Neisseria meningitides. Sulfamonomethoxine also active against Chlamydia spp., Toxoplasma gondii, Plasmodium. Rapidly absorbed from the gastrointestinal tract, it penetrates the BBB. The relatively low toxicity. Sulfamonomethoxine is a competitive inhibitor of dihydropteroate synthetase used to block the synthesis of folic acid. By preventing the production of folate in bacteria, the sulfonamide antibiotics ultimately suppress bacterial DNA replication.

CNS Activity

Curator's Comment: BACLEAN (Sulfamonomethoxine Sodium and Trimethoprim ) can rapidly penetrate the blood-brain barrier and maintain high blood concentration http://ft.chqmarket.com/en/1059-compound-sulfamonomethoxine-sodium-injection-baclean.html

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species.
2007
Patents

Patents

Sample Use Guides

adult: 1 tablet per day (500 mg- 1 g per day) children: 25 mg/kg per day at the first day, then 12,5 mg/kg per day
Route of Administration: Oral
In Vitro Use Guide
It was shown that 9 strains of P. mallei were sensitive to sulfanilamides and their combinations with trimethoprim: sulfamonomethoxine + trimethoprim (2.5:1), etc. The activity of the sulfamonomethoxine combination with trimethoprim (sulfate) was lower.
Name Type Language
SULFAMONOMETHOXINE SODIUM MONOHYDRATE
Common Name English
SULFAMONOMETHOXINE SODIUM [JAN]
Common Name English
BENZENESULFONAMIDE, 4-AMINO-N-(6-METHOXY-4-PYRIMIDINYL)-, MONOSODIUM, MONOHYDRATE
Common Name English
Code System Code Type Description
PUBCHEM
23724826
Created by admin on Sat Dec 16 05:52:52 GMT 2023 , Edited by admin on Sat Dec 16 05:52:52 GMT 2023
PRIMARY
FDA UNII
3O63314C1L
Created by admin on Sat Dec 16 05:52:52 GMT 2023 , Edited by admin on Sat Dec 16 05:52:52 GMT 2023
PRIMARY
SMS_ID
300000033591
Created by admin on Sat Dec 16 05:52:52 GMT 2023 , Edited by admin on Sat Dec 16 05:52:52 GMT 2023
PRIMARY